Ready to show the levels 📈 pat mccormack #McCormackDixon #SmithMaxwell

To start today’s #SmithMaxwell presser, new signing Shabaz Maverick Masoud and trainer Ben Davison join Eddie Hearn! Watch here: youtube.com/live/Xchr65GQZ…

Brains Bio President Terry O'Regan presents on Advancing the Cannabinoid Scientific Landscape at ICBC Berlin, emphasizing strategic partnerships and unlocking cannabinoid potential in pharmaceuticals. 🎙️🔬💡 #CannabinoidScience #PharmaInnovation #ICBCBerlin

🌿 Our team is thrilled to be exhibiting and presenting at the International Cannabis Business Conference in Berlin, Europe's largest B2B trade show and conference. We're excited to connect with industry professionals and share our expertise on EU GMP cannabinoids for the

𝗦𝘁𝗿𝗮𝗽 𝘀𝗲𝗮𝘀𝗼𝗻 🏆 pat mccormack ✨💫 First of many!

It's the Summer Patio Season! Connect with fellow GVBOT members and take in views of the North Shore mountains, on the patio at Brains Bioceutical! Register here: bit.ly/3NDfrMs

Check out photos from our Members' Social at the Brains Bioceutical Patio. A huge thanks to the Brains Bioceutical team and attendees for making the event possible. Visit our website for more such upcoming events: lnkd.in/gTx5psVc

#MadeBetter

Not long now until the 6th Annual Cannabinoid-Derived Drug Development Summit! We’re ready to discuss everything from translation, bioavailability, dosage, delivery and much more! dsm-firmenich Innovation Manager Alexandru Zabara and Brains Bioceutical Senior Vice President Barinder S. Bhullar

Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp's Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry. #MadeBetter finance.yahoo.com/news/brains-bi…

Fantastic wrap-up at #InternationalCBC! 🌿 We’re propelling #cannabinoid science & patient support forward. With EU-GMP ingredients, patient-first formats & uncompromised pharma standards, the full potential of cannabinoids is within reach. dsm-firmenich & Brains Bio continue to

We are thrilled to share that DSM-Firmenich has launched an advanced formulated CBD drug product intermediate, CBTru®, using Brains Bio's EU GMP certified CBD API. This milestone elevates patient health and marks a new era in the pharmaceutical cannabinoid industry. Our EU GMP

Brains Bioceutical Set to Achieve One of the World's First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare nationalpost.com/globe-newswire…

Join us at #CPHIWorldwide2024 to discuss our strategic partnerships and explore how our cannabinoid-based APIs can support your development needs. Schedule a meeting with us at lnkd.in/gv3C9Bk5 Learn more about our pioneering API offerings at brainsbio.com.

“The introduction of high-quality CBN API, D9 THC and CBG is a landmark moment for Brains Bio, and for the entire pharmaceutical industry,” financialpost.com/globe-newswire…

"This is a defining moment for Brains Bio and the industry,"said Rick Brar, CEO & Chairman of Brains Bio. "Consumers demand purity, consistency, and safety, and this approval validates our commitment to delivering pharmaceutical-grade, natural CBD." newswire.ca/news-releases/…